Medtelligence: Linking Science to Clinical Practice

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
CME/CE
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
- Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
CME/CE
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
- Kevin Alexander, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
CME/CE
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
- Ahmad Masri, MD, MS
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
MinuteCE®
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
0.50 program credits
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 program credits

IgA Nephropathy Updates: Evolving Guidelines and Practical Strategies
IgA Nephropathy Updates: Evolving Guidelines and Practical Strategies
Nephrology
IgA Nephropathy Updates: Evolving Guidelines and Practical Strategies
- Jörg Latus, MD
- Jürgen Floege, MD
Epilepsy: Beyond Seizure Impact
Epilepsy: Beyond Seizure Impact
MinuteCE®
Epilepsy: Beyond Seizure Impact
0.50 program credits
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 program credits
VNS: Beyond Seizure Control
VNS: Beyond Seizure Control
MinuteCE®
VNS: Beyond Seizure Control
0.50 program credits
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 program credits
MinuteCE®
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
0.50 credits 5 episodes
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 credits 5 episodes
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
CME/CE
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
1.00 credit
- Meena B. Bansal, MD, FAASLD
- Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
- Fernando Bril, MD
1.00 credit
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CE
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
- Piotr Ponikowski, MD, PhD, FESC, FHFA
0.25 credits
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CE
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
0.25 credits
- Pam R. Taub, MD, FACC, FASPC
- Jan T. Kielstein, MD, FASN, FERA
0.25 credits
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
- Stefan D. Anker, MD, PhD
- Mahir Karakas, MD, PhD, MBA